Page 26 - Serum Institute Of India

Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca's Covid-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said

Covid-19: Serum Institute to halt trial of Oxford vaccine after DCGI notice

On Tuesday, AstraZeneca had decided to stop trials after a participant fell sick with an unexplained illness.

What Serum Institute's persistence on Oxford vaccine trials means for India

The company is going ahead regardless of AsraZeneca pausing trials in UK after an adverse impact was reported

Indian-origin professor's UK firm strikes Covid-19 vaccine deal with India

The firm, SpyBiotech which is led by Prof Sumi Biswas, is an Oxford University spinoff company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases

Isha, Akash Ambani, Byju, Poonawalla debut on Fortune's '40 under 40' list

The list covers five sectors including finance, technology, health, government/politics and media/entertainment

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Phase II clinical trial of Oxford Covid-19 vaccine begins in Pune

The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at a medical college and hospital here on Wednesday. Two male volunteers were administered the vaccine at Bharti Vidyapeeth's Medical College and Hospital, a senior office-bearer of the hospital said. The trial began around 1 pm, he said. "Doctors at the hospital administered the first shot of the 'Covishield' vaccine to a 32-year-old man after his reports of COVID-19 and antibodies tests came out negative," Medical Director of Bharti Vidyapeeth's Medical College, Hospital and Research Centre, Dr Sanjay Lalwani, said. Another 48-year-old male volunteer was also given the vaccine, he added. While the 32 year-old volunteer works for a private company, the other one is associated with the healthcare sector, he said. "Before administering the vaccine, doctors checked their temperature, blood pressure and heart beats," he said. Five volun

Covishield vaccine to be sold only after successful trial: Serum Institute

SII issued this clarification after reports in the media began appearing which claimed that Covishield- Oxford University's vaccine candidate, will be commercialised in a little over two months

Second Russian Covid-19 vaccine 'EpiVacCorona' shows promise: Report

The vaccine elicits an immune response after double administration with the interval of 14-21 days

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Expects to complete trials by year-end

Expert committee on Covid-19 vaccine administration to meet on Wednesday

The Serum Institute of India, Pune has also been permitted for conducting Phase 2 and 3 human clinical trials of the Oxford University-developed Covid-19 vaccine

India weighs options in debate on who gets first shot of Covid-19 vaccine

Companies wait for government orders as top medical research group says health workers must get first inoculation

Serum Institute to provide Covid vaccine to 92 countries at Rs 250 a dose

Partners with Gavi, Gates Foundation, will provide 100 mn doses to Covax, a WHO initiative led by Gavi and CEPI

Serum Institute to price Covid-19 vaccine at less than Rs 250/dose in India

As per SII, the vaccines will be available as early as the first half of 2021 after gaining approvals and qualifications from the WHO

Novavax signs Covid-19 vaccine supply deal with India's Serum Institute

The Indian drugmaker will have exclusive rights for the vaccine in India during the term of the deal

'Our sort of moment': Indian billionaires bet big in Covid-19 vaccine race

Serum Institute, the world's largest vaccine producer, has announced a plan to make hundreds of millions of doses of an unproven inoculation. 'I hope we don't go in too deep,' says CEO Adar Poonawalla

More than enough doses of Covid-19 vaccine reserved for Parsis: Poonawalla

Serum Institute CEO didn't specify quantity of doses to be kept for community grappling with shrinking population

Oxford Covid-19 vaccine trials in India: Serum Institute seeks DCGI nod

Initial results of the first two-phase trials of the vaccine conducted in five trial sites in the UK showed it has an acceptable safety profile and homologous boosting increased antibody responses

Adar Poonawalla: A rare risk-taking CEO with strong business acumen

Adar Poonawalla's Serum Institute has tied up with AstraZeneca-backed Oxford vaccine candidate for one billion doses which it will make for India and the GAVI vaccine alliance of 58 countries

Hotspots Mumbai, Pune to help test vaccine efficacy: Serum Institute

The high prevalence of COVID-19 infections in Mumbai and Pune will help test the efficacy of the vaccine developed by Oxford University and AstraZeneca, its local manufacturer SSI said